COAGULIN-B Trademark Information

Trademark by GENZYME CORPORATION

pharmaceutical preparations, namely, recombinant adeno-associated virus expressing factor IX, for the treatment of hemophilia

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere:: 9/1/1999
First Use In Commerce: 11/22/1999
General Information
Word mark: COAGULIN-B
Status/Status Date:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
3/7/2009
Serial Number: 75713772
Filing Date: 5/25/1999
Registration Number: 2576473
Registration Date: 6/4/2002
Goods and Services: pharmaceutical preparations, namely, recombinant adeno-associated virus expressing factor IX, for the treatment of hemophilia
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 8/8/2000
Last Applicant/Owner:
GENZYME CORPORATION
********
********
***** ****
Mark Drawing Code: Typeset (Words/letter/Number)
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
********
********
***** ****
Current Status:
CONTINUED USE NOT FILED WITHIN GRACE PERIOD, UN-REVIVABLE
3/7/2009
Correspondent Search:
Richard D. Allison is a correspondent of COAGULIN-B trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on